Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Embrapa Semiárido is a decentralized research unit of the Brazilian Agricultural Research Corporation (Embrapa) that focuses on developing biotechnological and agricultural solutions for semi-arid regions. The organization specializes in the genetic improvement of crops, irrigation technology, and the bioprospecting of native flora from the Caatinga biome to identify bioactive compounds for pharmaceutical and nutraceutical applications. Their work bridges the gap between agricultural productivity and life sciences, producing biofortified crops and veterinary health solutions. As a state-owned entity, it plays a pivotal role in the Brazilian bioeconomy by transforming regional biodiversity into commercial technologies and sustainable food products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Embrapa Semiárido.